Physicochemical properties of amorphous precipitates of cimetidine-indomethacin binary system.
We have found that the binary system, consisting of a precipitate of cimetidine and naproxen, became amorphous due to intermolecular interaction. In order to clarify the interaction between cimetidine and other drugs, the physicochemical properties of binary systems consisting of cimetidine and drugs, phenacetin, salicylamide or indomethacin, were investigated. X-ray powder diffraction patterns and thermal analysis findings for the precipitates indicated that the cimetidine-indomethacin system has an amorphous structure, whereas the cimetidine-phenacetin and cimetidine-salicylamide systems do not. Fourier-transform infra-red (FTIR) spectroscopy and nuclear magnetic resonance (NMR) spectroscopy findings suggested that there is an intermolecular interaction between a proton in the imidazole ring of cimetidine and the C=O in the COOH of indomethacin. Since an interaction by the hydrogen bond between cimetidine and indomethacin would prevent three-dimensional arrangements of the molecules, the precipitate would be amorphous. In the cimetidine-indomethacin system, decarboxylation of indomethacin occurred below the melting temperature, indicating that the chemical stability decreased upon precipitation. Cimetidine was found to interact with drugs with a carboxyl group. The interaction would be applicable to make the amorphous system of the drugs and increase the solubility of the drugs.
Yamamura
S
S
School of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi, Chiba, Japan. yamamura@phar.toho-u.ac.jp
Gotoh
H
H
Sakamoto
Y
Y
Momose
Y
Y
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000737:chemistry*; D000897:Anti-Ulcer Agents / Q000008:administration & dosage* / Q000737:chemistry*; D002152:Calorimetry, Differential Scanning; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D002851:Chromatography, High Pressure Liquid; D002927:Cimetidine / Q000008:administration & dosage* / Q000737:chemistry*; D004338:Drug Combinations; D004355:Drug Stability; D007213:Indomethacin / Q000008:administration & dosage* / Q000737:chemistry*; D009682:Magnetic Resonance Spectroscopy; D012995:Solubility; D017550:Spectroscopy, Fourier Transform Infrared; D014961:X-Ray Diffraction
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents; D004338:Drug Combinations; D002927:Cimetidine; D007213:Indomethacin